Delivery Order SPE2DB22D2007-SPE2DB25FJ3EW
- Not listed
- The Defense Logistics Agency awarded a $39,228.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 140 mg Imbruvica capsules. Under this order, Amerisourcebergen will deliver 90 capsules of Imbruvica to a facility in Conshohocken, Pennsylvania by September 28, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, Amerisourcebergen will fulfill this order to support the DLA's stocking of prescription drugs for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,467.48 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 140 mg capsules (90-count units). This firm fixed-price, competitively awarded delivery order carries an ultimate completion date of August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, demonstrating AmerisourceBergen's continued capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) with delivery to Conshohocken, Pennsylvania. This contract, awarded on August 4, 2025, utilizes a firm fixed-price structure with an ultimate completion date of August 25, 2025. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) under a firm fixed-price contract. This delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract utilizes a delivery order mechanism,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,233.74 for IMBRUVICA 140 mg capsules (90-count units) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on July 28, 2025, with an ultimate completion date of August 18, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $37,878.75 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $47,074 delivery order to Amerisourcebergen Drug Corporation for 140 mg Imbruvica capsules. Under this firm fixed price contract, Amerisourcebergen will deliver 90 capsules of Imbruvica to a location in Conshohocken, Pennsylvania by July 31, 2023, in support of the Defense Logistics Agency's pharmaceutical procurement programs. As the prime contractor, Amerisourcebergen will be responsible for fulfilling the order without the use of major subcontractors....
- The Defense Logistics Agency awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count packaging) under a firm fixed price contract type. The delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide IMBRUVICA 420 mg tablets. The $43,936.02 order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA to deliver a wide range of pharmaceuticals and medical supplies to support military treatment facilities worldwide. This order does not have a...
- The Defense Logistics Agency Troop Support Medical awarded a $15,691 delivery order to Amerisourcebergen Drug Corporation for 140mg Imbruvica capsules. Under this firm fixed price contract, Amerisourcebergen will deliver 90 capsules of Imbruvica to a location in Conshohocken, Pennsylvania. The order is being funded through the DLA Troop Support Medical portfolio to support Department of Defense pharmacotherapy needs. Amerisourcebergen will perform as the prime contractor, with work taking...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3EWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,350.61 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units). This firm fixed-price delivery order, issued on July 22, 2025, will be completed by August 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-competitive set-aside award and falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9 million through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal healthcare vendor serving military and veteran healthcare systems through the DLA Medical Supply Chain. The company's SPE2DX prime IDC vehicle enables comprehensive global pharmaceutical support, covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. This delivery order for Imbruvica, a specialty oncology medication, exemplifies AmerisourceBergen's role in fulfilling critical pharmaceutical requirements within the federal military healthcare supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 7/22/25 |